guroldinneden / iStock Editorial / Getty Images Plus / Getty

NIH Clinical Trials Policy debate

Read a range of authoritative views and guidance on NIH's new clinical trials policy, which affects the majority of US human behaviour researchers. 

Latest Research

  • Review Article |

    Hilbe et al. synthesize recent theoretical work on zero-determinant and ‘rival’ versus ‘partner’ strategies in social dilemmas. They describe the environments under which these contrasting selfish or cooperative strategies emerge in evolution.

    • Christian Hilbe
    • , Krishnendu Chatterjee
    •  & Martin A. Nowak
  • Letter |

    An analysis of more than 30,000 national polls from 351 general elections in 45 countries over the period between 1942 and 2017 shows that, contrary to popular belief, election polling misses have not become more prevalent.

    • Will Jennings
    •  & Christopher Wlezien
  • Perspective |

    The social science of happiness needs to recognize the importance of social connection and prosocial action for human well-being and become more interdisciplinary with greater collaboration, especially among social scientists and policymakers.

    • John F. Helliwell
    •  & Lara B. Aknin

News & Comment

  • News & Views |

    Polling problems in recent elections have called into question whether sample surveys can still produce valid data. A new study provides reassurance.

    • Scott Keeter
  • News & Views |

    Growing evidence links adverse childhood experiences to health problems decades later. A study of adults followed in midlife finds that perceived social support predicts lower subsequent mortality, particularly for adults reporting child abuse, suggesting that supportive relationships buffer long-term health in the context of early maltreatment.

    • Ann S. Masten
  • News & Views |

    Asymmetric social boundaries allow a minority culture to reap the benefits of outside interaction while maintaining its distinctiveness. This opens questions about the nature of intergroup interactions and whether such boundaries are the only way to preserve valued cultural norms.

    • Adrian Viliami Bell

About the Journal

  • Nature Human Behaviour publishes research of outstanding significance into any aspect of human behaviour: its psychological, biological, and social bases, as well as its origins, development, and disorders. The journal aims to enhance the visibility of research into human behaviour, strengthening its societal reach and impact.
  • We publish a range of content types including original research articles, Reviews, Perspectives, Comments, News, and Features that elaborate on significant advances in the field and cover topical issues.
  • Nature Human Behaviour is staffed by a dedicated team of professional editors, with relevant research backgrounds. It is led by Stavroula Kousta, formerly the Editor of Trends in Cognitive Sciences and Senior Editor at PLOS Biology, and also includes John Carson and Anne-Marike Schiffer.
  • Editorial office, institutional access, advertising and marketing


  • Witchcraft beliefs are and have been widespread in human societies, but what impact do they have on social interactions and what cultural evolutionary function might they serve? Field experiments and network data show that the witchcraft label ‘Zhu’ influences labour-sharing and reproductive choices in a large network of southwest Chinese villages. Zhu is not an indicator of prosociality, but may function to spite or damage rivals.


Clinical Trials

guroldinneden / iStock Editorial / Getty Images Plus / Getty

Clinical Trials

As of January 25, 2018, the NIH, the biggest funder of biomedical research in the world, is implementing policy changes which will affect the majority of US laboratories working with human subjects. We think it is vital for all parties, external stakeholders and the public to engage in an informed, productive debate about these developments to identify issues and opportunities. In this special collection of commissioned opinion pieces, representatives of international funding agencies and science regulators, non-profit organizations and think tanks, and leading basic and clinical researchers in the US and Europe contribute novel, thought-provoking arguments. In an accompanying Q&A, Michael Lauer of the NIH addresses questions regarding the implementation and gives advice on future grant applications.

Natureevents Directory